Intelligent anti-aging skin care based on independent research     
Lose wrinkles, keep your bank account!     
 
Skin Care 101
Skin Care Basics
Skin Protection
Skin Biology
Biology of Aging
Ingredient Guide
Skin & Nutrition
Skin Conditions
 
Anti-Aging Treatments
Topical Actives
Wrinkle Fillers
Noninvasive
Invasive
 
Skin Care Smarts
Smart Choices
Best Practices
Find Good Skin Doc
Quick Tips
Freebie Finder
 
Reviews & Research
Product Reviews
Provider Reviews
Skin Care Research
Clinical Trials
 
How-To Infopacks
Skin Rejuvenation
DIY Skin Care
Skin & Nutrition
Eye Skin Care
Longevity In a Pill
 
Community & Misc
Forums
Polls & Surveys
News and Updates
Search

-- advertisements --
   
You are here: Clinical Trials >

Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)

Information provided by Dresden University of Technology
Information obtained from ClinicalTrials.gov on June 16, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) treated: Acne Papulopustulosa

Intervention: Differin Gel (Drug)

Phase: Phase 4

Enrollment status: Recruiting

Sponsor: Dresden University of Technology

Principal investigator(s) or official(s):
Roland Aschoff, MD, Principal Investigator, Affiliation: Technische Universität Dresden, Fetscher Str. 74, 01307 Dresden, Germany

Overall contact:
Roland Aschoff, MD, Phone: 0049-351-458, Ext: 2007, Email: Roland.Aschoff@mailbox.tu-dresden.de

Summary

The aim of the study is to investigate the effectivity of visible light in combination with waterfiltered infrared in treating acne papulopustulosa. The reduction of inflammatory and non-inflammatory lesions within 8 weeks will be measured and compared with the standard treatment with Adapalene.

Clinical Details

Official title: Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)

Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Primary outcome: reduction of inflammatory and non-inflammatory lesions within 8 weeks after start of therapy

Eligibility

Minimum eligible age: 14 Years. Eligible gender(s): Both.

Criteria:

Inclusion Criteria:

- Mild to moderate acne papulopustulosa according to Burton Scale Stage 3 to 4

- At least 5 inflammatory and 5 non-inflammatory lesions in the face

- Age >= 14 years

Exclusion Criteria:

- pregnant and nursing women

- Antiandrogen therapy

- therapy with antibiotics within the last 4 weeks

- therapy with retinoids within the last 6 months

- natural or artificial UV-therapy within the last 4 weeks

- severe acne papulopustulosa according to Burton Scale 5 or 6

- Severe systemic condition

- Secondary acne

Locations and Contact Information

Roland Aschoff, MD, Phone: 0049-351-458, Ext: 2007, Email: Roland.Aschoff@mailbox.tu-dresden.de

Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Sachsen 01307, Germany; Recruiting
Roland Aschoff, MD, Phone: 0049-351-458, Ext: 2007, Email: Roland.Aschoff@mailbox.tu-dresden.de
Additional Information

Start date: September 2006
End date: September 2009
Last updated: May 22, 2008


Google
 
Web SmartSkinCare.com

Home | About Us | Contact Us | Ask a Question | Resources

Copyright © 1999-2008 by Dr. G. Todorov / SmartSkinCare.com
Site Disclaimer | Copyright Certification

   
-- advertisements --